MedPath

Double blind, Randomize control trial ; Intraarticular triamcinolone acetone post arthroscopic lysis adhesion prevent recurrent stiffness of the knee.

Phase 4
Conditions
Study on knee range of motion and pain score after arthroscopic release of stiff knee
Arthroscopic release
Stiff knee
TA injection
Registration Number
TCTR20200322005
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
24
Inclusion Criteria

-Patient who was diagnosed as Arthrofibrosis knee and under went arthroscopic lysis adhesion.

Exclusion Criteria

Active infection
Extra-articular course stiff knee
Chronic inflammatory joint disease (RA SLE)
Knee stiffness from tumor
Nerve or spine injury
Previous operative management of stiff knee.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knee ROM at 1, 6, 12 week post operative at 1, 6, 12 week post operative Range of motion as degree
Secondary Outcome Measures
NameTimeMethod
VAS at 1, 6, 12 week post operative at 1, 6, 12 week post operative Visual analog score
© Copyright 2025. All Rights Reserved by MedPath